Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
The classification of Amoxicillin includes Capsule, Tablet and Other and the proportion of Capsule in 2017 is about 80%, and the proportion is in decreasing trend from 2013 to 2018.
Amoxicillin is widely sales through Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. The most proportion of Amoxicillin is sales through Retail Pharmacy, and the consumption proportion is about 62.7% in 2017.
For Amoxicillin API market, at present, Asia's enterprise technology is developing fast, and the Asia companies mainly supply the domestic market. India and China is the major countries in the world.
According to this study, over the next five years the Amoxicillin market will register a 0.6% CAGR in terms of revenue, the global market size will reach US$ 4620 million by 2024, from US$ 4470 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Amoxicillin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Amoxicillin market by product type, application, key manufacturers and key regions and countries.
This study considers the Amoxicillin value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Capsule
Tablet
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GSK
Novartis
Centrient Pharma
Teva
Mylan
Cipla
NCPC
United Laboratories
Sun Pharma
CSPC
LKPC
Hikma
Dr. Reddy
HPGC
Aurubindo
Meiji Holdings
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Amoxicillin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Amoxicillin market by identifying its various subsegments.
Focuses on the key global Amoxicillin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Amoxicillin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Amoxicillin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
